Welcome to our dedicated page for Palomar Holdings SEC filings (Ticker: PLMR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Palomar Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Palomar Holdings's regulatory disclosures and financial reporting.
Palomar Holdings Chief Risk Officer Jonathan Knutzen reported RSU-related transactions. On February 18, 2026, he exercised 612 Restricted Stock Units, which converted into 612 shares of common stock. Following this, he directly held 27,860 shares of Palomar common stock.
On the same date, 281 shares of common stock were sold at $128.04 per share. A footnote explains these shares were automatically sold by the company under a mandatory sell-to-cover provision to satisfy minimum statutory tax withholding obligations triggered by the RSU vesting. After this sale, Knutzen directly owned 27,579 common shares, including 1,386 shares purchased through the company’s 2019 Employee Stock Purchase Plan.
Jon Christianson filed a notice of proposed sale under Rule 144 covering 612 shares of common stock with an aggregate market value of 77,730, to be sold through Morgan Stanley Smith Barney LLC on or about 02/18/2026 on the NASDAQ market. The issuer has 26,494,524 shares of this class outstanding. Christianson acquired 1,020 restricted common shares from the issuer as compensation on 02/18/2026. Over the prior three months, he has already sold multiple blocks of common shares, including 522 shares for gross proceeds of 67,254 on 11/18/2025 and 1,691 shares for 235,895 on 12/23/2025, as well as additional sales in January 2026.
PLMR insider Chris Uchida filed a notice of proposed stock sales under Rule 144. The filing covers 918 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 116,595 and 26,494,524 shares outstanding.
The securities to be sold were acquired on 02/18/2026 as restricted stock from the issuer as compensation, totaling 1,530 shares acquired on that date. Over the past three months, Uchida has also sold 782, 2,103, 1,326, and 545 common shares on prior dates, with respective gross proceeds of 100,753, 252,108, 161,829, and 66,351.
Armstrong Mac reported open-market sale transactions in a Form 4 filing for PLMR. The filing lists transactions totaling 5,000 shares at a weighted average price of $122.60 per share. Following the reported transactions, holdings were 343,388 shares.
Palomar Holdings insider Mac Armstrong has filed a notice to sell 5,000 shares of common stock through Morgan Stanley Smith Barney on or around 02/12/2026, with the shares listed on NASDAQ. The filing shows 26,501,692 common shares outstanding at the time the notice was prepared.
The 5,000 shares to be sold were recently acquired as restricted stock units, including 2,061 units and 2,939 units that vested on 01/31/2026 and 01/29/2026. Over the past three months, Armstrong and the Armstrong Family Trust have already sold multiple blocks of Palomar common stock, such as 11,484 shares on 01/28/2026 for about $1.38 million and 5,000 shares on 01/21/2026 under a Rule 10b5-1 plan.
Palomar Holdings reported very strong fourth quarter and full year 2025 results, driven by rapid premium growth and higher profitability. For Q4 2025, net income rose to $56.2 million, or $2.06 per diluted share, up from $35.0 million, or $1.29, a year earlier. Adjusted net income increased to $61.1 million, or $2.24 per diluted share.
Fourth quarter gross written premiums grew 31.8% to $492.6 million, while the combined ratio was 76.8% and adjusted combined ratio 73.4%, indicating solid underwriting profitability. Annualized return on equity reached 24.7%, with annualized adjusted return on equity of 26.9%.
For full year 2025, gross written premiums climbed 31.5% to $2.0 billion. Net income increased 67.6% to $197.1 million, and adjusted net income rose 61.9% to $216.1 million. The full year combined ratio improved to 76.9% and adjusted combined ratio to 72.7%, supporting a 23.6% return on equity. The company issued 2026 guidance for adjusted net income of $260 million to $275 million, which includes an estimate of $8 million to $12 million of catastrophe losses.
Palomar Holdings, Inc. President filed an amended insider transaction report correcting the transaction date for previously reported equity activity. The Form 4/A now reflects a transaction date of 01/29/2026 instead of the earlier clerical entry.
The filing shows the exercise of restricted stock units (RSUs) into common stock, including 1,327 shares from a grant originally covering 3,979 RSUs awarded on 01/29/2024 and 1,787 shares from a grant of 5,360 RSUs awarded on 01/29/2025. Both grants vest in three equal annual installments, subject to continued service, and the RSU transactions were reported at an exercise price of $0.00.
Palomar Holdings, Inc. insider activity centers on RSU vesting and a corrective amendment. The Chief Risk Officer exercised restricted stock units into 1,230 and 1,434 common shares at an exercise price of $0.00 on 01/29/2026. The company then automatically sold 381 shares at $122.042 under a mandatory sell-to-cover provision to satisfy tax withholding tied to the vesting event. After these transactions, the officer directly held 25,658 common shares and derivative holdings of restricted stock units, including grants originally covering 3,692 shares from 01/29/2024 and 4,302 shares from 01/29/2025 that vest in three equal annual installments. This Form 4/A also corrects the previously reported transaction date, which had been misstated due to a clerical error.
Palomar Holdings, Inc. reported an amended insider transaction for its Chief People Officer involving restricted stock units. On 01/29/2026, 610 restricted stock units vested and were converted into 610 shares of common stock at a conversion price of $0.00, leaving 1,219 derivative securities beneficially owned on a direct basis.
The filing explains that the original RSU grant was for 1,829 shares on 01/29/2025, vesting in three equal annual installments conditioned on continued service. This amendment corrects a previously reported transaction date that was wrong due to a clerical error.
Palomar Holdings’ Chief Legal Officer, Angela Grant, filed an amended Form 4 to correct the transaction date for a prior insider transaction, noting the earlier date error was clerical. On 01/29/2026, 1,094 shares of common stock underlying RSUs were acquired at $0.00 upon vesting. That same day, 397 shares were automatically sold at $122.042 per share under a mandatory sell-to-cover provision to satisfy minimum tax withholding obligations. Following these transactions, Grant directly beneficially owned 5,939 shares of Palomar common stock.